Cassava Sciences (SAVA) stock faces uncertainty after a major late-stage trial setback for the company's Alzheimer's candiate ...

Constellation Energy challenges grid operator over rules for supplying electricity to data centers, facing opposition from ...

Meta's dual-pronged strategy leverages user engagement and AI-driven advertising to maintain dominance in social media. CEO ...

Cognizant Technology Solutions excels in AI and operational efficiency. Find out why CTSH stock is a hold, despite solid ...

Siemens Healthineers faces short-term challenges but offers long-term growth potential in imaging and radiation oncology, ...

Carlyle Secured Lending's 9.4% yield and strong liquidity make it a solid choice for investors. Find out why CGBD stock is a ...

Two Street analysts weigh in on Amgen's phase 2 MariTide data, saying that they would like to see additional details on the ...

Bank OZK's preferred stock offers a 6.8% yield and is supported by a rock-solid business model and exemplary management, ...

RBC Capital has initiated coverage of Dyne Therapeutics (DYN) and Avidity Biosciences (RNA) with outperform ratings, citing ...

AAON’s AI-driven growth boosts margins and free cash flow. Find out why AAON stock presents a strong opportunity with ...

I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic ...

The US economy remains on track to end the year with a moderate increase in output, according to the median Q4 GDP estimate ...